Genfit S Ais A Biopharmaceutical Company Based In Loosfranceestablished In 1999The Company Specializes In Developing Therapeutic And Diagnostic Solutions For Metabolic And Liver Related Diseasesparticularly Focusing On Conditions Like Non Alcoholic Steatohepatitisnashand Primary Biliary Cholangitispbcgenfit S Therapeutic Pipeline Includes Several Key Productselafibranor Is In Phase 3 Trials For Pbcwhile Gns561 Is In Phase 1B 2A Trials For Cholangiocarcinomaother Candidates Include Vs 01 For Urea Cycle Disordersand Vs 01 Aclf And Nitazoxanide For Acute On Chronic Liver Failurethe Company Also Offers Diagnostic Solutionssuch As The Nis4 Technology For Diagnosing Nash And Fibrosisand Nashnextwhich Is Licensed To Labcorp For Commercialization Genfit Is Committed To Advancing Precision Medicine For Liver Diseases Through Integrated Solutions And Strategic Partnershipsincluding Collaborations With Labcorp And Genoscience Pharma
